Published in Regen Med on November 01, 2008
Towards organ printing: engineering an intra-organ branched vascular tree. Expert Opin Biol Ther (2010) 1.24
Acellular biomaterials: an evolving alternative to cell-based therapies. Sci Transl Med (2013) 1.05
Implantation of completely biological engineered grafts following decellularization into the sheep femoral artery. Tissue Eng Part A (2014) 0.97
Enhancing Cell therapies from the Outside In: Cell Surface Engineering Using Synthetic Nanomaterials. Nano Today (2011) 0.96
From banking to international governance: fostering innovation in stem cell research. Stem Cells Int (2011) 0.93
The expanding world of tissue engineering: the building blocks and new applications of tissue engineered constructs. IEEE Rev Biomed Eng (2012) 0.92
Regenerative medicine in rheumatic disease-progress in tissue engineering. Nat Rev Rheumatol (2012) 0.84
Tissue Engineering of Blood Vessels: Functional Requirements, Progress, and Future Challenges. Cardiovasc Eng Technol (2011) 0.83
Induced pluripotent stem cell-derived vascular smooth muscle cells: methods and application. Biochem J (2015) 0.83
Effect of bone marrow-derived extracellular matrix on cardiac function after ischemic injury. Biomaterials (2012) 0.82
Improved recellularization of ex vivo vascular scaffolds using directed transport gradients to modulate ECM remodeling. Biotechnol Bioeng (2013) 0.79
Tissue engineered scaffolds for an effective healing and regeneration: reviewing orthotopic studies. Biomed Res Int (2014) 0.77
Effectiveness of haemodialysis access with an autologous tissue-engineered vascular graft: a multicentre cohort study. Lancet (2009) 5.16
Human tissue-engineered blood vessels for adult arterial revascularization. Nat Med (2006) 3.39
Mechanical properties of completely autologous human tissue engineered blood vessels compared to human saphenous vein and mammary artery. Biomaterials (2008) 1.68
Technology insight: the evolution of tissue-engineered vascular grafts--from research to clinical practice. Nat Clin Pract Cardiovasc Med (2007) 1.50
Quilty effect correlates with biopsy-proven acute cellular rejection but does not predict transplanted heart coronary artery vasculopathy. J Heart Lung Transplant (2009) 1.42
Pulmonary hypertension - intra- and early postoperative management in patients undergoing lung transplantation. Kardiol Pol (2009) 1.39
The evolution of vascular tissue engineering and current state of the art. Cells Tissues Organs (2011) 1.15
Rapid activation of Ras by fluid flow is mediated by Galpha(q) and Gbetagamma subunits of heterotrimeric G proteins in human endothelial cells. Arterioscler Thromb Vasc Biol (2003) 1.03
Case study: first implantation of a frozen, devitalized tissue-engineered vascular graft for urgent hemodialysis access. J Vasc Access (2011) 0.88
Expression of versican isoform V3 in the absence of ascorbate improves elastogenesis in engineered vascular constructs. Tissue Eng Part A (2010) 0.84
New biological solutions for hemodialysis access. J Vasc Access (2011) 0.77
[Reversibility of pulmonary hypertension assessment as an expected standard of diagnosis and prognosis on cardiology ward in Poland]. Kardiol Pol (2009) 0.75
Influence of panel reactive antibodies (PRA) on perioperative course in patients undergoing elective cardiac surgery procedures, and impact of these procedures on PRA occurrence. Ann Transplant (2006) 0.75
Vascular abnormalities and cardiomyocyte lipofuscin deposits in endomyocardial biopsy specimens of heart transplant recipients: are they related to the development of cardiac allograft vasculopathy? J Thorac Cardiovasc Surg (2009) 0.75
[Cardiac surgery in dialysis-patients with end-stage renal failure]. Kardiol Pol (2010) 0.75
Percutaneous coronary interventions in patients with transplanted heart coronary artery disease. Effects of intracoronary stent implantation on long-term results. Kardiol Pol (2004) 0.75